Bayer launches biotech innovation platform in China
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
IND application for EB-003 expected in early 2026
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Subscribe To Our Newsletter & Stay Updated